-
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial2021 The Lancet article Medicine Occupational and environmental lung diseases Open access cited by 4 patents
Arnaud Scherpereel, Anna K. Nowak, Nobukazu Fujimoto, Solange Peters, Anne S. Tsao, Aaron Scott Mansfield, +13 more
1,233citations -
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial2020 The Lancet article Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents
Philip J. Mease, Proton Rahman, Alice Bendix Gottlieb, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie Lillian Xu, +5 more
359citations -
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial
Marieke E. Gimbel, Khalid Qaderdan, Laura M. Willemsen, Rik S. Hermanides, Thomas O. Bergmeijer, Evelyn de Vrey, +10 more
357citations -
SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses2022 The Lancet article Medicine Respiratory viral infections research Open access cited by 1 patent
Maaike C. Swets, Annemarie Beth Docherty, Nazir Lone, Geert H. Groeneveld, Malcolm Gracie Semple, John Kenneth Baillie
348citations -
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
Richard A. Lafayette, Jens Halkjaer Kristensen, Andrew M. Stone, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, +6 more
334citations -
Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial
Susanne G. H. Olthuis, F.A.V. Pirson, Florentina M.E. Pinckaers, Wouter H. Hinsenveld, Daan Nieboer, Angelique Ceulemans, +56 more
258citations -
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation
Kuniaki Takahashi, Patrick W.J.C. Serruys, Valentı́n Fuster, Michael E. Farkouh, John A. Spertus, David J. Cohen, +10 more
209citations -
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
Doortje I Krijbolder, Marloes Verstappen, Bastiaan T van Dijk, Yousra J. Dakkak, Leonie E. Burgers, Aleid C. Boer, +10 more
183citations -
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
Andrew Paul Cope, Marianna Jasenecova, Joana Carvalho Vasconcelos, Andrew D. Filer, Karim Raza, Sumera Qureshi, +61 more
182citations -
Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial
Christiaan van der Leij, Bert A. Bonsing, Bas Groot Koerkamp, Vincent Erwin de Meijer, Lois A. Daamen, Stefan A.W. Bouwense, +5 more
179citations -
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial
Wouter van der Steen, Rob A. van de Graaf, Vicky Chalos, Hester Floor Lingsma, Pieter Jan van Doormaal, Jonathan M. Coutinho, +57 more
143citations -
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Atul A. Deodhar, Filip E Van den Bosch, Denis Poddubnyy, Walter P. Maksymowych, Désirée M F M van der Heijde, Tae‐Hwan Kim, +7 more
142citations -
Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial
Jürgen Beck, Christian Fung, Daniel Strbian, Lukas Bütikofer, Werner Josef Z'Graggen, Matthias F. Lang, +43 more
126citations